. "The leaked papers reveal a number of U.S. objectives: to make it impossible to challenge a patent before it is granted; to lower the bar required to get a patent (so that even drugs that are merely new forms of existing medicines, and do not show a therapeutic improvement, can be protected by monopolies); and to push for new forms of intellectual property enforcement that give customs officials exc" . . .